Dr. Charles Byrd, MD

NPI: 1225056328
Total Payments
$15,414
2024 Payments
$1,922
Companies
68
Transactions
1,110
Medicare Patients
2,564
Medicare Billing
$245,340

Payment Breakdown by Category

Food & Beverage$15,341 (99.5%)
Education$72.49 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $15,341 1,100 99.5%
Education $72.49 10 0.5%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,827 137 $0 (2024)
Gilead Sciences, Inc. $1,205 81 $0 (2024)
Amgen Inc. $1,097 84 $0 (2024)
PFIZER INC. $1,035 70 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $969.93 81 $0 (2023)
Allergan, Inc. $804.71 79 $0 (2020)
Lilly USA, LLC $788.34 56 $0 (2024)
GlaxoSmithKline, LLC. $760.62 56 $0 (2024)
AstraZeneca Pharmaceuticals LP $734.64 46 $0 (2024)
Novo Nordisk Inc $648.24 42 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,922 118 ABBVIE INC. ($330.69)
2023 $2,064 139 AbbVie Inc. ($518.86)
2022 $1,875 136 ABBVIE INC. ($347.81)
2021 $2,505 182 AbbVie Inc. ($294.75)
2020 $2,137 144 Allergan, Inc. ($368.71)
2019 $1,764 149 Gilead Sciences, Inc. ($252.76)
2018 $1,743 130 Takeda Pharmaceuticals U.S.A., Inc. ($229.12)
2017 $1,404 112 Takeda Pharmaceuticals America, Inc. ($165.24)

All Payment Transactions

1,110 individual payment records from CMS Open Payments — Page 1 of 45

Date Company Product Nature Form Amount Type
12/18/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $8.21 General
12/17/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $32.64 General
Category: HIV
12/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $10.03 General
Category: NEUROSCIENCE
12/13/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $9.65 General
Category: RESPIRATORY
12/12/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $16.55 General
Category: PSYCHIATRY
12/10/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $20.13 General
Category: Diabetes
12/09/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $15.09 General
Category: PAIN
12/04/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $18.56 General
Category: RESPIRATORY
12/04/2024 PFIZER INC. PAXLOVID (Drug) Food and Beverage In-kind items and services $17.59 General
Category: INFECTIOUS DISEASES
11/27/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $14.51 General
Category: Inflammation
11/25/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $13.55 General
Category: PSYCHIATRY
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.43 General
Category: Gastroenterology
11/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.38 General
Category: NEUROSCIENCE
11/13/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $24.09 General
Category: Oncology
11/12/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $11.25 General
Category: RESPIRATORY
11/11/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $17.25 General
Category: PAIN
11/11/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $13.85 General
Category: NEUROSCIENCE
11/07/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $8.71 General
Category: Inflammation
11/06/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $24.36 General
Category: Diabetes Care
11/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.62 General
Category: PSYCHIATRY
10/31/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.31 General
10/31/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $14.68 General
Category: TESTOSTERONE REPLACEMENT THERAPY
10/28/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $13.73 General
Category: DIABETES
10/22/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.90 General
Category: RESPIRATORY
10/14/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $19.72 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 705 904 $111,775 $71,284
2022 8 630 859 $102,585 $66,640
2021 7 585 809 $97,275 $61,384
2020 7 644 899 $86,200 $46,034
Total Patients
2,564
Total Services
3,471
Medicare Billing
$245,340
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 265 437 $48,070 $26,016 54.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 195 195 $29,250 $25,142 86.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 89 112 $17,920 $10,040 56.0%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 29 29 $5,800 $4,771 82.3%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 15 15 $3,000 $2,478 82.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $1,680 $983.73 58.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 17 19 $1,425 $818.82 57.5%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 59 61 $3,590 $546.14 15.2%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 13 13 $930.00 $450.06 48.4%
81002 Urinalysis, manual test Office 2023 11 11 $110.00 $37.51 34.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 258 451 $49,610 $28,739 57.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 164 164 $24,600 $21,664 88.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 82 95 $15,200 $7,894 51.9%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 21 21 $4,200 $3,536 84.2%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 16 16 $3,200 $2,695 84.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 23 25 $1,875 $1,073 57.2%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 19 39 $780.00 $634.23 81.3%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 47 48 $3,120 $404.65 13.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 280 475 $52,070 $31,096 59.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 120 120 $18,050 $16,225 89.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 101 124 $19,560 $9,951 50.9%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2021 17 17 $3,500 $2,916 83.3%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 16 19 $1,410 $730.70 51.8%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 38 39 $2,535 $412.76 16.3%
81002 Urinalysis, manual test Office 2021 13 15 $150.00 $52.20 34.8%

About Dr. Charles Byrd, MD

Dr. Charles Byrd, MD is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225056328.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Byrd, MD has received a total of $15,414 in payments from pharmaceutical and medical device companies, with $1,922 received in 2024. These payments were reported across 1,110 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($15,341).

As a Medicare-enrolled provider, Byrd has provided services to 2,564 Medicare beneficiaries, totaling 3,471 services with total Medicare billing of $245,340. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Family Medicine
  • Location Austin, TX
  • Active Since 07/17/2006
  • Last Updated 07/27/2011
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1225056328

Products in Payments

  • VRAYLAR (Drug) $1,115
  • NURTEC ODT (Drug) $729.20
  • JARDIANCE (Drug) $626.34
  • XIFAXAN (Drug) $534.63
  • TRINTELLIX (Drug) $520.23
  • UBRELVY (Drug) $516.36
  • Aimovig (Biological) $508.79
  • EMGALITY (Drug) $508.42
  • TRELEGY ELLIPTA (Drug) $456.97
  • Trintellix (Drug) $401.58
  • Otezla (Drug) $344.72
  • QULIPTA (Drug) $294.88
  • Ozempic (Drug) $283.94
  • AJOVY (Biological) $273.33
  • UNITHROID (Drug) $260.74
  • Rybelsus (Drug) $257.03
  • CHANTIX (Drug) $226.85
  • SYMBICORT (Drug) $215.25
  • Repatha (Biological) $211.18
  • LINZESS (Drug) $168.55

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Austin